Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events

Circulation

Volumn 102, Issue 13, 2000, Pages 1503-1510

  Pitt, Bertram ^a,e   Byington, Robert P ^b   Furberg, Curt D ^b   Hunninghake, Donald B ^c   Mancini, G B John ^d   Miller, Michael E ^b   Riley, Ward ^b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c University of Minnesota Hospital/Clinic   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Amlodipine; Angina; Angiography; Atherosclerosis; Revasculariz ation; Trials; Ultrasonics

Indexed keywords

AMLODIPINE BESYLATE; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; B SCAN; CAROTID ARTERY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0034718574     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.13.1503     Document Type: Article

References (26)

1. Retardation of angiographic progression of coronary artery disease by nifedipine: Results of the International Nifedipine Trial of Antiatherosclerotic Therapy (INTACT)
2. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis
3. Atherosclerotic plaque rapture and thrombosis: Evolving concepts
4. Vulnerable and dangerous coronary plaques
5. Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction
6. Rationale, design and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)
7. Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies
8. Risk of gastrointestinal hemorrhage with calcium antagonists in hypertensive persons over 67 years old
9. Automated quantitative coronary arteriography: Morphologic and physiologic validation in vivo of a rapid digital angiographic method
10. A multicenter comparison of the effects of randomized medical and surgical treatment of mildly symptomatic patients with coronary artery disease and a registry of consecutive patients undergoing coronary angiography
11. Analysis strategies for serial multivariate ultrasonographic data that are incomplete
12. Pravastatin, lipids, and major coronary events
13. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events
14. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS): A randomized controlled trial
15. Random effects models for longitudinal data
16. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
17. Compensatory enlargement of human atherosclerotic coronary arteries
18. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: The Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993
19. Common carotid intimal-media thickness and risk of stroke and myocardial infarction
20. The roles of carotid arterial intimal-media thickness in predicting clinical coronary events
21. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: The Heart Outcomes Prevention Evaluation Study Investigators
22. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
23. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
24. Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial
25. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease